loadpatents
name:-0.0035359859466553
name:-0.005126953125
name:-0.00043487548828125
Lundell; Daniel Patent Filings

Lundell; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lundell; Daniel.The latest application filed is for "3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands".

Company Profile
0.6.13
  • Lundell; Daniel - Flemington NJ
  • Lundell; Daniel - Flemigton NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
App 20110213029 - Taveras; Arthur G. ;   et al.
2011-09-01
Treatment of chemokine mediated diseases
Grant 7,960,433 - Taveras , et al. June 14, 2
2011-06-14
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands
App 20090306079 - Taveras; Arthur G. ;   et al.
2009-12-10
Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands
App 20080090823 - Biju; Purakkattle J. ;   et al.
2008-04-17
Nucleic acids encoding human TNF-.alpha. convertase
Grant 7,358,352 - Dalie , et al. April 15, 2
2008-04-15
Cxcr1 And Cxcr2 Chemokine Antagonists
App 20070248594 - Chao; Jianhua ;   et al.
2007-10-25
Treatment of chemokine mediated diseases
App 20070155756 - Taveras; Arthur G. ;   et al.
2007-07-05
Mammalian TNF-alpha convertases
App 20070141603 - Dalie; Barbara ;   et al.
2007-06-21
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20070021494 - Taveras; Arthur G. ;   et al.
2007-01-25
Mammalian TNF-.alpha. convertases
Grant 7,135,555 - Dalie , et al. November 14, 2
2006-11-14
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,132,445 - Taveras , et al. November 7, 2
2006-11-07
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
App 20060223864 - Biju; Purakkattle J. ;   et al.
2006-10-05
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
App 20060025453 - Taveras; Arthur G. ;   et al.
2006-02-02
CXCR1 and CXCR2 chemokine antagonists
App 20060014794 - Chao; Jianhua ;   et al.
2006-01-19
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040147559 - Taveras, Arthur G. ;   et al.
2004-07-29
Treatment of chemokine mediated diseases
App 20040053953 - Taveras, Arthur G. ;   et al.
2004-03-18
Mammalian TNF-alpha convertases
App 20020106781 - Dalie, Barbara ;   et al.
2002-08-08
Mammalian TNF-.alpha. convertases
Grant 5,853,977 - Dalie , et al. December 29, 1
1998-12-29
Expression of human inducible nitric oxide synthase
Grant 5,744,340 - Fossetta , et al. April 28, 1
1998-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed